Kanjinti

Trastuzumab-Anns

6.7 Moderate risk

Kanjinti & Off label use

15.7%

of users reported Off label use

72.2%

also reported Severe reaction

95.8%

are women

Most common medical consequences

Severe reaction
72.2%
Hospitalization
25.0%
Life-threatening condition
2.8%

Have you experienced any negative side effects from this medication?

Kanjinti: general information

Most common side effects (19)

Most commonly affected ages

40 - 49 years
8.8%
50 - 59 years
48.8%
60 - 69 years
42.4%
On this page
Kanjinti & Off label use
Kanjinti: general information